The role of a novel mineralocorticoid receptor antagonist, finerenone, in chronic kidney disease: mechanisms and clinical advances.

导出 LinkOut

翻译打印收藏纠错

第一作者： Xinping,Chen

第一单位： Department of Nephrology, Affiliated Hospital of Weifang Medical University, Weifang, 261031, China.

作者： Xinping,Chen ^[1] ; Xuan,Li ^[2] ; Kexin,Zhang ^[3] ; Kexin,Lian ^[1] ; Wenqiang,Zhang ^[2] ; Yixin,Song ^[3] ; Chengxia,Kan ^[1] ; Jingwen,Zhang ^[3] ; Fang,Han ^[4] ; Xiaodong,Sun ^[3] ; Zhentao,Guo ^[2]

作者单位： Department of Nephrology, Affiliated Hospital of Weifang Medical University, Weifang, 261031, China. ^[1] Clinical Research Center, Affiliated Hospital of Weifang Medical University, Weifang, 261031, China. ^[2] Department of Endocrinology and Metabolism, Affiliated Hospital of Weifang Medical University, 2428 Yuhe Road, Weifang, 261031, China. ^[3] Department of Pathology, Affiliated Hospital of Weifang Medical University, Weifang, 261031, China. ^[4] Clinical Research Center, Affiliated Hospital of Weifang Medical University, Weifang, 261031, China. xiaodong.sun@wfmc.edu.cn. ^[5] Department of Endocrinology and Metabolism, Affiliated Hospital of Weifang Medical University, 2428 Yuhe Road, Weifang, 261031, China. xiaodong.sun@wfmc.edu.cn. ^[6] Department of Nephrology, Affiliated Hospital of Weifang Medical University, Weifang, 261031, China. guozt@wfmc.edu.cn. ^[7] Clinical Research Center, Affiliated Hospital of Weifang Medical University, Weifang, 261031, China. guozt@wfmc.edu.cn. ^[8]

关键词 Chronic kidney disease Fibrosis Finerenone Inflammation Mineralocorticoid receptor

主题词动物(Animals);高钾血症(Hyperkalemia);肾功能不全, 慢性(Renal Insufficiency, Chronic);萘啶类(Naphthyridines);糖尿病, 2型(Diabetes Mellitus, Type 2)

DOI 10.1007/s10157-023-02413-2

PMID 37847437

发布时间 2024-01-26

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交